SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-3,668 Cr | ₹-4,215 Cr | ₹-3,932 Cr | ₹-3,487 Cr | ₹-2,818 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹-3,668 Cr |
| Mar2025 | ₹-4,215 Cr |
| Mar2024 | ₹-3,932 Cr |
| Mar2023 | ₹-3,487 Cr |
| Mar2022 | ₹-2,818 Cr |
How is Deferred Tax Assets / Liabilities of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-3,668 Cr | Negative | |
| Mar2025 | ₹-4,215 Cr | Negative | |
| Mar2024 | ₹-3,932 Cr | Negative | |
| Mar2023 | ₹-3,487 Cr | Negative | |
| Mar2022 | ₹-2,818 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,627.1 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
| MANKIND PHARMA | ₹96,179.6 Cr | -2.9% | -4.2% | -6.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | -2.9% |
-2.3% |
21.8% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses